Loading live market data…

Avalo Therapeutics, Inc.

NASDAQ:AVTX

$18.42 USD

$0 (0.0%)

Volume
13.6K
Average Volume
1.99M
Market Capitalization
$208.04M
P/E Ratio
-3.16
Dividend Yield
0.00%
Price Target
$46.50
Year High
$24.27
Year Low
$4.81
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$7.66

AVTX Estimated and Actual Revenue by Quarter

AVTX Estimated and Actual EPS by Quarter

AVTX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -16.22M -16.22M -16.22M - - -
2027-09-30 0 -13.47M -13.47M -13.47M - - -
2027-06-30 0 -12.03M -12.03M -12.03M - - -
2027-03-31 0 -10.59M -10.59M -10.59M - - -
2026-12-31 0 -12.32M -12.32M -12.32M - - -
2026-09-30 0 -13.92M -6.13M -9.94M - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 2 -0.80667 -0.80667 -0.80667
2027-09-30 0 - - - 2 -0.67 -0.67 -0.67
2027-06-30 0 - - - 2 -0.59833 -0.59833 -0.59833
2027-03-31 0 - - - 3 -0.52667 -0.52667 -0.52667
2026-12-31 0 - - - 3 -0.61273 -0.61273 -0.61273
2026-09-30 0 - - - 7 -0.69236 -0.30497 -0.49454